PROGRAM CHAIRS
Marian Rewers MD, PhD
Professor of Pediatrics & Medicine
Richard S. Abrams Endowed Chair
Executive Director, Barbara Davis Center for Diabetes
Aurora, CO
Brigitte Frohnert MD, PhD
Associate Professor of Pediatrics
Barbara Davis Center for Diabetes
University of Colorado
Anschutz Medical Campus
Aurora, CO
FACULTY
*ALL* faculty from:
Barbara Davis Center for Diabetes, University of Colorado, Anschutz Medical Campus, Aurora, CO
Kimber Simmons, MD, MPH, Associate Professor of Pediatrics
Holly O’Donnell, PhD, Assistant Professor of Pediatrics
Cristy Geno Rasmussen, MPH, PhD, Assistant Professor of Pediatrics
Patricia Gesualdo, RN, MSPH, Senior Research Instructor
Hali Broncucia, MA, Research Instructor
Rachel Karban, MPH, STOP T1D Program Coordinator
Kathleen Waugh, MS, Senior Research Instructor
Kimberly Bautista, MPH, Research Instructor
Andrea Steck, MD, Professor of Pediatrics
Iman Taki, STOP T1D Coordinator
Flor Sepulveda, Research Services Program Manager
PROGRAM OVERVIEW
This online enduring program is a comprehensive educational program for health care providers (HCPs) in the United States interested in type 1 diabetes (T1D) screening and monitoring programs. This activity aims to raise awareness among HCPs and communities about the critical importance of early detection and the severe consequences of delayed diagnosis of type 1 diabetes. In addition, it will educate and empower HCPs and healthcare organizations with the knowledge, competence, and tools necessary for effective screening, age-specific monitoring practices, and timely diagnosis.
TARGET AUDIENCE
This activity is designed to meet the educational needs of HCPs such as physicians, nurses, dieticians, and other advanced practitioners who care for children and adults with and without type 1 diabetes.
LEARNING OBJECTIVES
Upon completion of the activity, HCPs will have improved ability to:
- Understand the significance of early detection and intervention for T1D.
- Be familiar with islet autoimmunity screening methods.
- Explain the process of positive screening result confirmation.
- Develop effective strategies for result notification, ensuring clarity and patient understanding.
- Be familiar with monitoring protocols to track high-risk individuals with positive screening results.
- Recognize the psychosocial impact of screening and monitoring on the patient and family.
- Discuss the role of clinical trials and FDA-approved interventions in delaying onset of symptomatic T1D.
- Collaborate with interdisciplinary teams to provide comprehensive care to individuals at high-risk of developing T1D.
- Identify the key components of healthcare organizations required for effective pre-symptomatic diabetes screening and monitoring.
- Describe screening strategies for relevant demographic groups.
JOINT ACCREDITATION STATEMENT
In support of improving patient care, Med Learning Group is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
PHYSICIAN CREDIT DESIGNATION STATEMENT
Med Learning Group designates this enduring activity for a maximum of 2.5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.
NURSES (ANCC) CREDIT DESIGNATION
Med Learning Group designates this activity for a maximum of up to 2.5 ANCC contact hours.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPS
| Faculty Member | Disclosures |
| Marian Rewers, MD, PhD | Discloses that he has received consulting fees from Janssen, ProventionBio, and Sanofi. He has provided contracted research for Sanofi. |
| Brigitte Frohnert, MD, PhD | Discloses that she has received grant funding from Sanofi. |
| Kimber Simmons, MD | Discloses that she has received consulting fees and provided contracted research for Provention Bio, a Sanofi company. |
| Holly O’Donnell, PhD | Discloses that she has received consulting fees and honoraria for speaking from Sanofi. |
| Cristy Geno Rasmussen, MPH, PhD | Discloses that she has received consulting fees from Sanofi. |
| Patricia Gesualdo, RN, MSPH | Has nothing to disclose |
| Hali Broncucia, MA | Has nothing to disclose. |
| Rachel Karban, MPH | Has nothing to disclose. |
| Kathleen Waugh, MS | Has nothing to disclose. |
| Kimberly Bautista, MPH | Discloses that she has received consulting fees from Sanofi. |
| Andrea Steck, MD | Discloses that she has provided contracted research for Sanofi and Dompé farmaceutici. |
| Iman Taki | Has nothing to disclose. |
| Flor Sepulveda | Has nothing to disclose. |
All relevant financial relationships have been mitigated.
Content Review
The content of this activity was independently peer reviewed by a physician and nurse reviewer.
Individuals in Control of the Content of the Activity
The individuals in control of the content of this activity have reported the following financial relationships or relationships to products or devices they have with ineligible companies related to the content of this CE activity:
- Shpetim Karandrea, Ph.D., Medical Director for Med Learning Group, has nothing to disclose.
- Lauren Welch, MA, VP, Accreditation and Outcomes for Med Learning Group, has nothing to disclose.
- Aimee Meissner, Accreditation and Outcomes Coordinator for Med Learning Group, has nothing to disclose.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
METHOD OF PARTICIPATION
There are no fees for participating and receiving CE credit for this activity. In order to obtain your certificate for the mentioned accreditation, participants need to successfully complete the associated pre/post activities and evaluation. Your certificate will be provided as a downloadable file.
DISCLAIMER
Med Learning Group makes every effort to develop CE activities that are science based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.
For CE questions, please contact Med Learning Group at [email protected]
Contact this CE provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Event staff will be glad to assist you with any special needs (eg, physical, dietary, etc). Please contact Med Learning Group prior to participating at [email protected]
RELEASED DATE: June 06, 2024
EXPIRATION DATE: June 06, 2026
Copyright ©2024 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.
